The jury will enter the third day of debate on Thursday in the fraud trial of failed blood test start-up Theranos founder Elizabeth Holmes.
Ms. Holmes, 37, faces two counts of conspiracy to commit wire fraud and nine counts of wire fraud for allegedly lying about Theranos’ technology for money and fame. If convicted, he could face up to 20 years in prison.
A jury of eight men and four women began deliberations on Monday and continued their discussions on Tuesday. His only question in court on Tuesday afternoon was whether he could take the jury instructions home. (The answer was no.) They had a Wednesday off.
If the deliberations are not completed on Thursday, they will resume on the date set by the judge.
In Silicon Valley, start-up founders are rarely prosecuted for their truth-seeking claims. Ms. Holmes, who emerged as a female founder in the male-dominated industry, deliberately molded himself after Apple’s Steve Jobs. She Launched Theranos in 2003, dropped out of Stanford University in 2004 and raised nearly $ 1 billion over the next decade from venture capitalists and wealthy family offices.
In 2015, an investigation by the Wall Street Journal found that Ms. Holmes praised Theranos’ blood test technology capabilities, as well as its relationship with pharmaceutical companies and the military. The company closed in 2018.
The case boils down to whether Ms. Holmes was meant to deceive investors, patients and others or she acted in good faith.
Prosecutors called 29 witnesses, wanting to prove that Ms. Holmes “chose fraud over business failure” through misleading reports, fake exhibitions, inaccurate marketing materials and other false claims.
Ms. Holmes defended himself for seven days. She re-introduced herself as a naive entrepreneur who was misled by those around her. In an emotional testimony, she accused Ramesh Balwani, the former chief operating officer of Theranos, of emotionally and physically abusing her during their secret, decade-long relationship. Mr. Balwani, known as Sunny, has denied the allegations.